For this year’s Targeted Therapies Forum, Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine and Associate Director, Biomarker Discovery for TCI, presents Genetic Testing in Lung Cancer.
In this video, Dr. Fred Hirsch talks briefly about Exon 20, and the importance of the Destiny Trial for patients with HER2.
For more, please visit http://cancerGRACE.org/.
To join the conversation, visit https://cancergrace.org/forum.